Skip to main content
. Author manuscript; available in PMC: 2017 Sep 29.
Published in final edited form as: Clin Colorectal Cancer. 2016 Feb 13;15(3):222–227. doi: 10.1016/j.clcc.2016.02.013

Table 2.

Any grade Imprime PGG-related adverse events occurring in ≥10% patients

Adverse events n (%)
Fatigue 7 (38.9)
Headache 4 (22.2)
Infusion related reaction 4 (22.2)
Chills 3 (16.7)
Diarrhea 3 (16.7)
Hypomagnesaemia 3 (16.7)
Abdominal pain 2 (11.1)
Elevated alanine aminotransferase 2 (11.1)
Elevated aspartate aminotransferase 2 (11.1)
Asthenia 2 (11.1)
Mucosal inflammation 2 (11.1)
Nausea 2 (11.1)
Stomatitis 2 (11.1)
Tachycardia 2 (11.1)
Vomiting 2 (11.1)

AEs reported by the investigator as possibly, probably, or definitely related to Imprime PGG are included.